Use of a disease risk score to compare serious infections associated with anti-tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients.

Curtis JR, Xie F, Chen L, Muntner P, Grijalva CG, Spettell C, Fernandes J, McMahan RM, Baddley JW, Saag KG, Beukelman T, Delzell E
Arthritis Care Res (Hoboken). 2012 64 (10): 1480-9

PMID: 22833479 · PMCID: PMC3687540 · DOI:10.1002/acr.21805

MeSH Terms (19)

Adalimumab Aged Aged, 80 and over Antibodies, Monoclonal Antibodies, Monoclonal, Humanized Antirheumatic Agents Arthritis, Rheumatoid Etanercept Female Follow-Up Studies Humans Immunoglobulin G Infections Infliximab Male Middle Aged Receptors, Tumor Necrosis Factor Risk Tumor Necrosis Factor-alpha

Connections (1)

This publication is referenced by other Labnodes entities: